MSAB通过抑制β-catenin-DDR2信号传递来限制骨关节炎的发展和进展

Ke Lu1,2,3, Zhidong Liao1,2, Jingwen Li1,4

  • 1Research Center for Computer-aided Drug Discovery, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

Bioactive materials
|January 15, 2025
PubMed
概括

一种新型的人体血清白蛋白 (HSA) 传递系统的甲基硫 AB (MSAB) 通过抑制Wnt/β-catenin信号传递和减少疼痛和软骨损伤,有效治疗骨关节炎 (OA).